CRBP 8-K 2026-11-10

Corbus Pharmaceuticals Holdings, Inc. (CRBP) 8-K dated 2026-11-10 — accession 0001193125-26-454476.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a biotechnology company listed on US.

CRBP: Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a…

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRBP revenue for 2022-12-31 was $0. Net income was -$42.3M. CRBP currently screens at market cap $102.3M.

Not investment advice. The CRBP SEC hub lists recent forms. The stock page is the research view.